Home0460 • HKG
add
Sihuan Pharmaceutical Holdings Group Ltd
Previous close
$0.72
Year range
$0.50 - $1.02
Market cap
6.67B HKD
Avg Volume
37.16M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 475.71M | 18.21% |
Operating expense | 513.62M | 37.16% |
Net income | -91.62M | -4,090.21% |
Net profit margin | -19.26 | -3,466.67% |
Earnings per share | — | — |
EBITDA | -151.84M | -135.94% |
Effective tax rate | 1.34% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.63B | -16.82% |
Total assets | 10.53B | -8.70% |
Total liabilities | 5.58B | -12.76% |
Total equity | 4.95B | — |
Shares outstanding | 9.24B | — |
Price to book | 1.53 | — |
Return on assets | -4.68% | — |
Return on capital | -8.36% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -91.62M | -4,090.21% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.
Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
CEO
Founded
2001
Website
Employees
2,667
